Navigation Links
Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Mutually Terminate Merger Agreement; Oracle Healthcare Acquisition Corp. Cancels Special Meeting
Date:3/4/2008

GREENWICH, Conn., March 4 /PRNewswire-FirstCall/ -- Oracle Healthcare Acquisition Corp. (the "Company") (OTC Bulletin Board: OHAQ) announced today that it has entered into an agreement with Precision Therapeutics, Inc. ("PTI") providing for the mutual termination of the Agreement and Plan of Merger, dated as of December 3, 2007 and amended on January 24, 2008 and February 25, 2008 (as amended, the "Merger Agreement"), by and among the Company, PTI Acquisition Sub, Inc. and PTI and the transactions contemplated thereby.

The Company and PTI determined that, due to currently prevailing market conditions, terminating the Merger Agreement was in the best interests of both the Company and PTI, as well as their respective stockholders.

In light of the termination of the Merger Agreement, the Company's board of directors has canceled the special meeting of stockholders of the Company that had been scheduled to occur on Wednesday, March 5, 2008 for the purpose of voting on the Merger Agreement.

Pursuant to the provisions of the Company's Amended and Restated Certificate of Incorporation, the Company will liquidate as promptly as practicable. The Company's board of directors has authorized the Company to commence a dissolution and liquidation process. This process will involve, among other things, the preparation of a plan of dissolution and a proxy statement by the Company (which will be subject to board approval), the filing of such proxy statement with, and (if applicable) clearance by, the Securities and Exchange Commission and a stockholders meeting to approve the dissolution and liquidation of the Company.

Forward Looking Statements:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Readers are cautioned not to place undue reliance on any such forward-looking statements, each of which speaks only as of the date made. Such statements are subject to certain risks and uncertainties which are disclosed in the Company's SEC reports, including the Form 10-K for the year ended December 31, 2007.

Contact: President and Chief Operating Officer

Oracle Healthcare Acquisition Corp.

(203) 862-7900


'/>"/>
SOURCE Oracle Healthcare Acquisition Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Oracle Introduces Remote Data Capture Onsite 4.5.3 With Extensive New Functionality for Investigative Site Personnel
2. Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Agree in Principle to Amend Merger Agreement to Reduce Consideration by 15%
3. Oracle Helps Mayo Clinic Improve Information Management
4. TCS, Oracle and DrugLogic Prescribe Safety in a Capsule(TM)
5. Cathedral Healthcare System to Pay U.S. $5.3 Million to Resolve Allegations Involving Inflated Charges to Obtain Higher Medicare Reimbursement
6. Bayer HealthCare and Juvaris BioTherapeutics Announce Major Licensing Agreement
7. Anthem Blue Cross and Blue Shields Promoting Healthcare Quality Program Improves Quality and Patient Safety in 19 Colorado Hospitals
8. Benefitfocus(R) Healthcare Video Portal Merges Community with Credibility
9. Prime Healthcare Services Enters Into Network Wide Contract With Aetna Health Plans
10. UPDATED: Catholic Healthcare West and SEIU Begin Negotiations for 15,000 Hospital Workers
11. Catholic Healthcare West and SEIU Begin Negotiations for 15,000 Hospital Workers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... February 11, 2016 , ... As part of their 2015 end of year ... Table Foundation (MDRTF), has gifted $10,000 to University of Chicago to support ovarian cancer ... Cundiff. , “We are honored to support a promising young investigator from Dr. Lengyel’s ...
(Date:2/10/2016)... ... February 10, 2016 , ... The ... World Molecular Imaging Congress (WMIC), will be held in New York City, NY ... “Imaging Biology…Improving Therapy.” The congress will highlight and emphasize how imaging reveals a ...
(Date:2/10/2016)... , ... February 10, 2016 , ... Early this week, ... and raise awareness of Nestlé KITKAT as the first global confectionery brand sourced from ... cocoa farmers and the quality of their product, through activities that focus on better ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... care communications company offering education, research and medical media, has launched ... working in infectious diseases. , As the all-inclusive resource for infectious disease ...
(Date:2/10/2016)... Walton Beach, Florida (PRWEB) , ... February 10, ... ... the innovative weather-forecasting company is unveiling its revolutionary new 2.0 version at the ... platform, MetLoop has “put the power of the world's most advanced weather technology ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ... fourth quarter and full year ended December 31, 2015. ... was a transformational year for Vanda with the continued ... market approval of HETLIOZ for Non-24," said Mihael H. ... Fanapt to our U.S. product portfolio builds on this ...
(Date:2/10/2016)... , February 10, 2016 ... Analyzers (Liquid & Gas), and Spectroscopy Market by Industry (Oil ... Beverage, Pulp & Paper, Metal & Mining, and Others), ... MarketsandMarkets, the global market is expected to grow to ... of 8.6% between 2015 and 2020. Browse ...
(Date:2/10/2016)... , Feb. 10, 2016  Resolve Therapeutics, ... transformative new approaches to the treatment of lupus ... of a multiple ascending dose study in patients ... compound RSLV-132. --> ... placebo-controlled multiple ascending dose study of RSLV-132 in ...
Breaking Medicine Technology: